SCHEMBL6980375

SCHEMBL6980375

O=S(=O)(Nc1ccc2ncccc2c1)c1cccc(Cl)c1

nearest known ligand 0.65

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.65
ALDH1A1 P00352 1/20 0.65
SMN1; SMN2 Q16637 1/20 0.65
SLC40A1 Q9NP59 1/20 0.62
PKM P14618 1/20 0.56
PFKFB3 Q16875 1/20 0.56
PGR P06401 9/20 0.56
MAPT P10636 2/20 0.55
TDP1 Q9NUW8 1/20 0.55
PTPN2 P17706 3/20 0.54
PTPN1 P18031 3/20 0.54
PTPN5 P54829 1/20 0.54
HSPD1 P10809 1/20 0.51
HSPE1 P61604 1/20 0.51
TP53 P04637 1/20 0.50
HTR7 P34969 1/20 0.49
HTR6 P50406 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2055421 0.90 ALDH1A1 (0.68) LMNAALDH1A1SMN1; SMN2SLC40A1PFKFB3
SCHEMBL6981076 0.87 ALDH1A1 (0.76) LMNAALDH1A1SMN1; SMN2SLC40A1MAPT
SCHEMBL6985862 0.85 ALDH1A1 (0.78) LMNAALDH1A1SMN1; SMN2SLC40A1PKM
SCHEMBL6980648 0.85 LMNA (0.65) LMNAALDH1A1SMN1; SMN2SLC40A1PKM
SCHEMBL6979083 0.83 SMN1; SMN2 (0.74) LMNAALDH1A1SMN1; SMN2PKMPFKFB3
SCHEMBL5377995 0.81 ALPL (0.72) LMNAALDH1A1SMN1; SMN2MAPT
SCHEMBL6982196 0.79 ALDH1A1 (0.76) LMNAALDH1A1SMN1; SMN2PFKFB3MAPT
SCHEMBL2055443 0.79 CYP3A4 (0.61) LMNAALDH1A1SMN1; SMN2SLC40A1PGR
SCHEMBL6978649 0.79 ALDH1A1 (1.00) LMNAALDH1A1SMN1; SMN2SLC40A1MAPT
SCHEMBL6978003 0.79 ALDH1A1 (0.76) LMNAALDH1A1SMN1; SMN2PFKFB3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed
EP-0991624-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT Boehringer Ingelheim Pharma KG (DE) 2000-04-12 EP disclosed
WO-1999000371-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-01-07 WO disclosed